| Aug 7, 2026 | AH Bio Fund IV LP, AH Equity Partners Bio IV LLC, Marc Andreessen, BENJAMIN HOROWITZ | 10% OWNER | BUY | 10.232M | $18.00 | $19.8M |
| Aug 7, 2026 | Erez Chimovits | DIRECTOR | BUY | 11.072M | $18.00 | $34.9M |
| Aug 7, 2026 | ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC | DIRECTOR | BUY | 11.072M | $18.00 | $34.9M |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief UA, Forbion Growth III Management BV, Forbion Ventures Fund VII Cooperatief UA, Forbion Ventures VII Management BV | — | BUY | 20.723M | $18.00 | $64.8M |
| Aug 7, 2026 | James Paul Rickey | CHIEF FINANCIAL OFFICER | BUY | 27.777K | $18.00 | $500K |
| Aug 7, 2026 | Christopher Viehbacher | DIRECTOR | BUY | 83.333K | $18.00 | $1.5M |
| Aug 7, 2026 | David Malek | DIRECTOR | BUY | 4.166K | $18.00 | $75K |
| Aug 7, 2026 | Michele Anderson | CHIEF DEVELOPMENT OFFICER | BUY | 1.111K | $18.00 | $20K |
| Aug 7, 2026 | Travis Murdoch | CEO AND PRESIDENT | BUY | 83.333K | $18.00 | $1.5M |
| Aug 7, 2026 | Charles David Lubner | DIRECTOR | BUY | 55.555K | $18.00 | $1000K |
